Overview
Dong-hyuk Sheen practices practicing medicine in Daejeon, Republic of Korea.
Their clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Uveitis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Dong-hyuk Sheen
Is Dong-hyuk Sheen a top-rated expert for Arthritis?
MediFind is an objective health platform that identifies experts based on real-world data. Dong-hyuk Sheen is classified as an Experienced expert for Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Dong-hyuk Sheen participate in research or clinical trials?
Yes. Dong-hyuk Sheen has published 8 articles and abstracts on conditions like Arthritis. You can view a list of Dong-hyuk Sheen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ankylosing SpondylitisSheen isExperienced. Learn about Ankylosing Spondylitis.
- ArthritisSheen isExperienced. Learn about Arthritis.
- Rheumatoid Arthritis (RA)Sheen isExperienced. Learn about Rheumatoid Arthritis (RA).
- UveitisSheen isExperienced. Learn about Uveitis.